Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > How long to BTD and then AA

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Apr 28, 2023 5:07pm

126 Views

Post# 35420120

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How long to BTD and then AA

Perhaps only patients which are CR or IR at 360 days have pending visits for potential CR/IR status. Those NR at 360 May perhaps not need and will be counted as NR? No reason why they won't be counted. Overall it looks like we should be seeing about 18-25 CR patients out of 37 ( 52-15 12undertreated plus 3 from PH1 removed from Swimmers plot. That would be 48-68% CR at 450 days half way thru trial pretty much. All IMHO. Pretty Amazing. All IMHO

<< Previous

Bullboard Posts

Next >>

Northstar Gold surveys large potential copper resource extension